Lipid clinics network. Rationale and design of the EAS global project

Abstract

The evidence of the causal role of low-density lipoprotein cholesterol in the development of atherosclerotic cardiovascular disease is well-established. The clearly identified common position of the European guidelines proclaims necessity to decrease LDL-C concentrations based on a proper risk stratification. However, current worldwide situation with the lipid management still demonstrates inadequate dyslipidemia control, that is probably related to a healthcare system issues. As the need to standardize and implement approaches following the guidelines into clinical practice remains a challenge, the EAS initiates the Lipid Clinics Network project, aiming to provide a structure to establish uniform EU-wide standards of diagnosis, management and treatment of patients with lipid disorders, based on the ESC/EAS Guidelines on management of dyslipidaemias.

Translating guidelines into practice via implementation science: an update in lipidology

“…The 2018 AHA/ACC guideline included a section on implementation [11] while the 2019 ESC/EAS guideline included implementation advice for lipid testing, risk assessment, and treatment adherence [31]. More recently the EAS has published practical guidance on lipid care and policy action [32–35]. Yet, frameworks and other guidance to incorporate implementation science into guidelines exist [14,36 ▪▪ ,37 ▪▪ ].…”